Navigation Links
Nuvilex Cites Study that Suggests Red Yeast Rice, an Active Ingredient in Cinnechol, Can Help to Improve Cardiovascular Health

Study Published in Annals of Internal Medicine

CHERRY HILL, N.J., June 24 /PRNewswire-FirstCall/ -- Nuvilex, Inc. (OTC Bulletin Board: NVLX), an emerging healthcare consumer products company, announced today that red yeast rice, an ingredient contained in Cinnechol, one of the Company's primary supplement products, has been recently proven to decrease levels of low-density lipoprotein, or LDL cholesterol, in dyslipidemic patients. LDL cholesterol is known more informally as "bad" cholesterol. Red yeast rice, which has been used in Ayurvedic medicine and China as a dietary supplement for centuries, contains a compound (monacolin K) that is identical in chemical composition to lovastatin, a commonly prescribed cholesterol-lowering drug.

A recent study titled "Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients: A Randomized Trial," led by cardiologists Dr. David Becker and Dr. Ram Gordon and published in the Annals of Internal Medicine, showed that a diet and exercise regimen that included red yeast rice reduced LDL cholesterol by an average of 27.3%, compared to 5.7% for the control group. Moreover, the study showed that red yeast rice can decrease LDL cholesterol without increasing pain levels.

"Many synthetic statins have been derived from red yeast rice and other naturally occurring phytochemicals," stated Robert Bowker, co-inventor of Cinnechol and President of Knock-Out Technologies, Ltd., a wholly owned subsidiary of Nuvilex. "Red yeast rice, among others, is a bona fide naturally occurring statin. Cinnechol--along with diet and exercise--can help individuals maintain normal cholesterol levels and promote cardiovascular health."

Cinnechol, which contains red yeast rice extract as well as a blend of other ingredients known to improve cardiovascular function (including niacin and guggul gum extract), may provide a natural alternative for those who have high cholesterol and are intolerant of, or elect not to take, statin drugs. Cinnechol can be purchased online by visiting

"Red yeast rice has now been more thoroughly researched and recognized as an important tool for safely normalizing blood lipids, especially LDL cholesterol," reported Cinnechol co-inventor Steven Kushner, Ph.D. "Cinnechol, by combining Red Yeast Rice with several cardiovascular beneficial synergists, also helps promote healthy total cholesterol levels, improved HDL (beneficial cholesterol) levels, and better blood viscosity."

About Cinnechol

Cinnechol, an ingestible capsule made of all-natural ingredients, is manufactured and sold by Cinnechol, Inc. (a wholly owned subsidiary of Nuvilex, Inc.). Cinnechol is designed to help maintain normal cholesterol levels and to support normal cardiovascular function. Cinnechol, along with a healthy diet and exercise regimen, is intended to serve as a dietary supplement to help individuals manage numerous cardiovascular and metabolic disorders (including dyslipidemia, hypertension, hypoglycemia, and hyperglycemia).

About Nuvilex, Inc.

Nuvilex, formerly, is an emerging healthcare consumer products company with a portfolio of aesthetics, dermatology, environmental and nutraceutical products. The company's focus is on developing, licensing and commercializing healthcare products that address the health needs of consumers worldwide. In March 2009, Nuvilex merged with Freedom2 Holdings, Inc., a diversified skin products technology company serving the fast-growing body art, aesthetic, cosmetic and skin therapy markets. More information is available at: or

Safe Harbor Statement

Statements contained in this presentation that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Forward-looking statements are sometimes identified by words such as "intends", "anticipates", "believes", "expects", and "hopes" and involve a number of risks and uncertainties that could cause the Company's actual results to differ materially from projected results. All parties are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company's products and services, the planned share exchange with Freedom2 Holdings, Inc., our ability to secure additional financing, and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.

    Investor Relations Contacts:

    Blair Barnes
    Senior Vice President and Chief Financial Officer
    Nuvilex, Inc.
    Ph: 856-433-6088

    Amy Glynn/Ashleigh Barreto
    The Ruth Group
    Ph: 646-536-7023/7028

    Press Contact:

    Pat Arcand
    Arcand & Madison
    Ph: 617-576-7777

SOURCE Nuvilex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Nuvilex Renews MedX Master Distribution Agreement and Implements New Pricing for Talsyn Scar Cream
2. Nuvilex Featured in Wall Street Reporter Interview
3. Nuvilex Offers Free Cinnergen Samples in Response to Spike in Consumer Interest
4. Nuvilex Launches Video Marketing Campaign
5. Nuvilex Gets Update from CK41 on purEffect(TM) Launch Plan
6. Nuvilex Signs Agreement with Jayhur Enterprises to Distribute Infinitink - the Worlds First Permanent, But Easier to Remove Tattoo Ink - in Australia and New Zealand
7. Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex
8. Nuvilex, Inc. Announces Monthly Investor Conference Call
9. Nuvilex Advances Release of Citroxin(TM) Antiviral Surface Cleaner to Help Combat Swine Flu
10. Nuvilex, Inc. Announces Investor Conference Call and Open House
11. Nuvilex, Inc.s Marketing Partner, CK41 to Launch purEffect(TM) in May
Post Your Comments:
(Date:11/27/2015)... ... 28, 2015 , ... There is only one major question facing all law ... , This question has not been an easy question to answer. Especially when the ... the younger workforce don’t share the same discipline around working long hours. , ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... According to ... out by the University of Toronto and the University of British Columbia suggested that ... for head injuries. The article explains that part of the reason for the controversial ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... affecting the health care in America. As people age, more care is needed, ... costs are rising, and medical professionals are being overworked. The forgotten part of ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... safe and convenient way to dispense prescription medications at home, so he invented ... way to monitor and dispense prescription medications. In doing so, it could help ...
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just ... is offering customers 10% off of their purchase of lice treatment product. In addition, ... price. According to a company spokesperson. “Finding lice is a sure way to ruin ...
Breaking Medicine News(10 mins):
(Date:11/29/2015)... 2015 CIVCO Medical Solutions will demonstrate ... Radiological Society of North America ... November 29 – December 4, 2015. The ... customers unrivaled versatility, enhanced user experience and deliver ... --> --> ...
(Date:11/27/2015)... YORK , November 27, 2015 ... system is set to go online. The potential to ... processes is vast and far from fully exploited as ... to patient health records, either via mobile tablet or ... ) --> ) --> ...
(Date:11/27/2015)... , Nov. 27, 2015 Research and Markets ... "Global Intrauterine Devices Market 2015-2019" report to ... --> In this report, the author the present ... market for 2015-2019. To calculate the market size, the ... type of products: Hormonal IUDs and copper IUDs. The ...
Breaking Medicine Technology: